Vistagen Therapeutics Inc (VTGN)
4.47
-0.19
(-4.08%)
USD |
NASDAQ |
May 08, 16:00
4.47
0.00 (0.00%)
After-Hours: 16:50
Vistagen Therapeutics Free Cash Flow: -26.12M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.12M |
| September 30, 2023 | -31.50M |
| June 30, 2023 | -41.67M |
| March 31, 2023 | -49.93M |
| December 31, 2022 | -58.04M |
| September 30, 2022 | -60.14M |
| June 30, 2022 | -55.28M |
| March 31, 2022 | -45.46M |
| December 31, 2021 | -35.18M |
| September 30, 2021 | -28.27M |
| June 30, 2021 | -15.86M |
| March 31, 2021 | -12.35M |
| December 31, 2020 | -9.621M |
| September 30, 2020 | -8.761M |
| June 30, 2020 | -13.80M |
| March 31, 2020 | -15.76M |
| December 31, 2019 | -16.74M |
| September 30, 2019 | -16.37M |
| June 30, 2019 | -16.29M |
| March 31, 2019 | -14.70M |
| December 31, 2018 | -13.74M |
| September 30, 2018 | -12.28M |
| June 30, 2018 | -10.10M |
| March 31, 2018 | -9.060M |
| December 31, 2017 | -7.979M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.632M |
| June 30, 2017 | -7.962M |
| March 31, 2017 | -7.501M |
| December 31, 2016 | -7.310M |
| September 30, 2016 | -6.386M |
| June 30, 2016 | -5.684M |
| March 31, 2016 | -4.835M |
| December 31, 2015 | -4.398M |
| September 30, 2015 | -3.565M |
| June 30, 2015 | -2.580M |
| March 31, 2015 | -2.769M |
| December 31, 2014 | -2.342M |
| September 30, 2014 | -2.319M |
| June 30, 2014 | -2.406M |
| March 31, 2014 | -2.136M |
| December 31, 2013 | -2.643M |
| September 30, 2013 | -3.418M |
| June 30, 2013 | -4.044M |
| March 31, 2013 | -3.599M |
| December 31, 2012 | -3.362M |
| September 30, 2012 | -3.332M |
| June 30, 2012 | -2.808M |
| March 31, 2012 | -3.566M |
| December 31, 2011 | -2.849M |
| September 30, 2011 | -1.792M |
Free Cash Flow Range, Past 5 Years
-60.14M
Minimum
Sep 2022
-8.761M
Maximum
Sep 2020
-29.32M
Average
-26.12M
Median
Dec 2023
Free Cash Flow Benchmarks
| Ardelyx Inc | -81.12M |
| Axsome Therapeutics Inc | -145.66M |
| Vir Biotechnology Inc | -800.36M |
| Immuneering Corp | -49.31M |
| NovaBay Pharmaceuticals Inc | -4.15M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.535M |
| Cash from Investing (Quarterly) | -0.0323M |
| Cash from Financing (Quarterly) | 93.52M |
| Free Cash Flow Per Share (Quarterly) | -0.1554 |
| Free Cash Flow to Equity (Quarterly) | -4.568M |
| Free Cash Flow to Firm (Quarterly) | -4.568M |
| Free Cash Flow Yield | -43.31% |